heroin dependence
Information
- Disease name
- heroin dependence
- Disease ID
- DOID:9976
- Description
- "An opiate dependence that involves the continued use of heroin despite problems related to use of the substance." [url:http\://en.wikipedia.org/wiki/Opioid_dependence]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04495673 | Completed | N/A | Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder | January 11, 2021 | February 22, 2022 |
| NCT00000211 | Completed | Phase 2 | Treatment Efficacy for Drug Abuse and AIDS Prevention - 2 | September 1989 | February 1996 |
| NCT00000273 | Completed | Phase 2 | A Laboratory Model for Heroin Abuse Medications - 8 | August 1995 | November 2005 |
| NCT00000302 | Completed | Phase 3 | Study Comparing Liquid and Tablet Buprenorphine Formulations - 5 | ||
| NCT00608504 | Completed | Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals. | July 2007 | April 2009 | |
| NCT00684554 | Completed | Phase 2/Phase 3 | Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial | December 2007 | April 2010 |
| NCT00684840 | Completed | Effects of Stress and Other Factors on Opiate Drug Choice. | March 2008 | December 2011 | |
| NCT00698737 | Completed | Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC) | April 2008 | November 2012 | |
| NCT00759005 | Completed | N/A | Effect of Stress on Heroin-Related Memory Retrieval | March 2007 | September 2008 |
| NCT00894452 | Completed | Variance of Oral Methadone Dosage: Description of Implicated Factors | December 2008 | May 2013 | |
| NCT01315184 | Completed | Phase 2 | Study of Computer-Based Treatment for Drug Dependence | July 2010 | July 2012 |
| NCT01447212 | Completed | Phase 3 | Study to Assess Longer-term Opioid Medication Effectiveness (SALOME) | December 2011 | February 2016 |
| NCT01471145 | Completed | Phase 4 | Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT | January 2013 | October 2014 |
| NCT01536925 | Completed | Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects | December 2011 | April 2017 | |
| NCT01668706 | Completed | Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts | March 2009 | December 2013 | |
| NCT01723527 | Completed | Phase 1 | Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin | December 2012 | August 2014 |
| NCT01760473 | Completed | Phase 3 | Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone | May 2009 | December 2014 |
| NCT01999946 | Completed | Phase 4 | Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry | June 27, 2014 | December 24, 2020 |
| NCT02324725 | Completed | Phase 4 | Biomarkers of Injectable Extended Release Naltrexone Treatment | October 2011 | December 2021 |
| NCT02774954 | Completed | N/A | Change the Cycle: An RCT to Prevent Injection Initiation | June 2016 | November 2019 |
| NCT03015246 | Completed | Phase 1/Phase 2 | Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence | December 2016 | August 2020 |
| NCT03071315 | Completed | Economic Evaluation Comparing CCT With MMT in Hai Phong City, Vietnam | January 20, 2013 | January 30, 2015 | |
| NCT04133974 | Completed | N/A | Methadone Induced Memory Retrieval-extinction Procedure in Heroin Addicts | November 20, 2015 | April 20, 2019 |
| NCT00000210 | Completed | Phase 2 | Treatment Efficacy for Drug Abuse and AIDS Prevention - 1 | September 1989 | February 1996 |
| NCT00015171 | Completed | Phase 3 | Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1 | April 1996 | June 1997 |
| NCT00015288 | Completed | Phase 1 | Buprenorphine and Naloxone Combination Study - 10 | November 1996 | |
| NCT00023283 | Completed | Phase 2 | Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1 | August 2000 | February 2004 |
| NCT00032955 | Completed | Phase 3 | Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1 | February 2001 | August 2002 |
| NCT00032968 | Completed | Phase 3 | Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1 | January 2001 | August 2002 |
| NCT00135759 | Completed | Phase 2 | Addition of Naltrexone to Methadone Taper | April 2005 | July 2006 |
| NCT00142948 | Completed | Phase 2 | Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts | February 2006 | May 2011 |
| NCT00149669 | Completed | N/A | Employment-based Reinforcement of Naltrexone Ingestion and Abstinence | December 2005 | December 2010 |
| NCT00158288 | Completed | Phase 2 | The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 | March 1997 | August 2001 |
| NCT00218127 | Completed | Phase 2 | Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens | November 2001 | July 2005 |
| NCT00218309 | Completed | Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals | September 2003 | July 2005 | |
| NCT00218361 | Completed | Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals | August 2005 | ||
| NCT00218426 | Completed | Phase 2/Phase 3 | Addiction Treatment in Russia: Oral vs. Naltrexone Implant | July 2006 | November 4, 2010 |
| NCT00218530 | Completed | Phase 1 | Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1 | March 2003 | September 2004 |
| NCT00218634 | Completed | N/A | Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1 | February 2005 | July 2009 |
| NCT00238914 | Completed | Phase 2 | Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 | August 1999 | July 2002 |
| NCT00249457 | Completed | N/A | Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 | October 1996 | January 2006 |
| NCT00249470 | Completed | N/A | The Therapeutic Workplace Initiation Study | April 2003 | October 2004 |
| NCT00249574 | Completed | N/A | Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1 | June 2003 | June 2006 |
| NCT00279110 | Completed | Phase 2/Phase 3 | Directly Administered HIV Therapy in Methadone Clinics | April 2006 | May 2011 |
| NCT00310934 | Completed | Phase 4 | A Stepwise Strategy Utilizing Buprenorphine and Methadone | August 2005 | March 2006 |
| NCT00326235 | Completed | Phase 4 | Effects of Buspirone in Opiate Withdrawal | January 2002 | July 2004 |
| NCT00429767 | Completed | Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Dependent Individuals | January 2007 | January 2010 | |
| NCT00471042 | Completed | Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care | June 2006 | August 2012 | |
| NCT00476242 | Completed | Phase 2/Phase 3 | Memantine as a Supplement to Naltrexone in Treating Heroin Dependence | June 2008 | August 2011 |
| NCT00577408 | Completed | Phase 3 | Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone | September 2007 | August 2011 |
| NCT03711318 | Terminated | Phase 3 | Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals | November 1, 2018 | December 31, 2021 |
| NCT01395797 | Terminated | Phase 1/Phase 2 | Pioglitazone for Heroin and for Nicotine Dependence | March 2011 | June 2014 |
| NCT00609089 | Unknown status | Phase 1/Phase 2 | Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction | March 2008 | June 2013 |
| NCT03229642 | Unknown status | N/A | Repetitive Transcranial Magnetic Stimulation in Patients With Opioid Use Disorders | August 1, 2017 | December 31, 2022 |
| NCT03557632 | Unknown status | N/A | University of Houston Drug Abuse Research Development Program II | August 1, 2014 | March 31, 2020 |
| NCT01144390 | Unknown status | N/A | Effect Study of Optimized Intervention to Heroin Addicts | April 2010 | June 2011 |
| NCT02524912 | Unknown status | Methadone Maintenance Outcome Study in Taiwan: 5-year Follow-up | April 2015 | March 2017 | |
| NCT02541500 | Unknown status | Phase 3 | An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence | April 2013 | January 2017 |
| NCT02541513 | Unknown status | Phase 3 | An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence | May 2013 | January 2017 |
| NCT02541526 | Unknown status | Phase 3 | Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia | May 2013 | May 2017 |
| NCT03922659 | Unknown status | N/A | Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Heroin Dependence | June 30, 2019 | December 2021 |
| NCT04003077 | Unknown status | N/A | Laser Meridian Massage in Heroin Addicts | February 26, 2019 | April 16, 2020 |
| NCT00726960 | Unknown status | Phase 1 | Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers | January 2008 | June 2010 |
| NCT00000329 | Withdrawn | Phase 2 | Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4 | April 1999 | August 1999 |
| NCT00000330 | Withdrawn | Phase 2 | Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5 | October 1999 | November 1999 |
| NCT00000331 | Withdrawn | Phase 2 | Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 | December 2002 | December 2002 |
| NCT00000328 | Withdrawn | Phase 2 | Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3 | July 1997 | August 1997 |
| NCT00000326 | Withdrawn | Phase 2 | Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1 | April 1997 | August 1997 |
| NCT00000327 | Withdrawn | Phase 2 | Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2 | June 1997 | August 1997 |
| NCT00709007 | Withdrawn | Phase 2/Phase 3 | Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India | July 2008 | July 2011 |
- Disase is a (Disease Ontology)
- DOID:2559
- Cross Reference ID (Disease Ontology)
- MESH:D006556
- Cross Reference ID (Disease Ontology)
- NCI:C34694
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:191817000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0019337
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006556